Abstract Details

Title Natalizumab Treatment of Multiple Sclerosis Leads to Diminished Microglial Activation in the Normal Appearing White Matter

Topic Multiple Sclerosis

Presentation(s) P3 - (-)

Poster/Presentation
Number 390

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Laura Airas, MD, PhD (Turku University Hospital) PRESENTER	Dr. Airas has nothing to disclose.
Marcus Sucksdorff, MD (University of Turku)	Dr. Sucksdorff has nothing to disclose.
	No disclosure on file
Eero Rissanen, MD (C/o Turku University Hospital)	Dr. Rissanen has received research support from Sigrid Juselius Foundation.

��ɫ��